Rankings
▼
Calendar
ANNX Q3 2023 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena
ANNX
Annexon, Inc.
$713M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$35M
Net Income
-$32M
EPS (Diluted)
$-0.43
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$28M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$204M
Total Liabilities
$47M
Stockholders' Equity
$157M
Cash & Equivalents
$133M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$35M
-$36M
+3.6%
Net Income
-$32M
-$35M
+7.3%
← FY 2023
All Quarters
Q4 2023 →